Skip to main content
. 2015 Jun 29;10(6):e0131680. doi: 10.1371/journal.pone.0131680

Fig 1. DcR3 Fc administration protects mice from CLP-induced lethality.

Fig 1

Mice were randomly divided into four groups (ten mice/group): sham, CLP, CLP plus Ig Fc, and CLP plus DcR3 Fc. For the CLP plus DcR3 Fc group, 100 μg DcR3 Fc was intravenously infused 30 min before and 6 h after CLP. For CLP plus Ig Fc, 100 μg Ig Fc was intravenously infused 30 min before and 6 h after CLP. Other groups received the same volume of saline as a control. Survival was monitored for 7 d. Survival rates were analyzed using log-rank tests. *p <0.05.